MENU
BCAX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Bicara Therapeutics (BCAX) Ownership - Who owns Bicara Therapeutics?
Bicara Therapeutics Inc is a clinical-stage biopharmaceutical company bringing transformative bifunctional therapies to patients with solid tumors... Show more
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
630.98M
P/E Ratio
N/A
Total Cash
462.07M
Projected Growth
N/A
Total Debt
591K
Revenue
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
8.47
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
BCAX
Capitalization
631M
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
462M
Total Cash/Share
8.47
Total Debt
591K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
459M
P/B Ratio
1.37
Cash Flow
N/A
Earnings
-1.69
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
7K
Current Ratio
24.62
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-108.74M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-19.31
Shares Held By Institutions
786M
Shares Outstanding - Current
54.5M
Total Liabilities
19.1M
Total Volume MTD
N/A
Value
1
Gain YTD
-33.582
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information